Stay updated on RC48-ADC in HER2+ Urothelial Cancer Clinical Trial
Sign up to get notified when there's something new on the RC48-ADC in HER2+ Urothelial Cancer Clinical Trial page.

Latest updates to the RC48-ADC in HER2+ Urothelial Cancer Clinical Trial page
- Check5 days agoNo Change Detected
- Check13 days agoNo Change Detected
- Check20 days agoChange DetectedThe page's revision label was updated to v3.5.4, replacing the previous v3.5.3. This indicates a new version of the page.SummaryDifference0.1%

- Check27 days agoNo Change Detected
- Check41 days agoChange DetectedThe page’s displayed interface revision/version text has been updated from v3.5.2 to v3.5.3, with no indication of changes to the underlying clinical-trial information.SummaryDifference0.1%

- Check48 days agoChange DetectedRevision updated from v3.5.0 to v3.5.2.SummaryDifference0.1%

- Check77 days agoChange DetectedRevision updated from v3.4.3 to v3.5.0 on the page. This appears to be a minor metadata change rather than a substantive modification to study content.SummaryDifference0.1%

- Check84 days agoChange DetectedRevision updated from v3.4.2 to v3.4.3 to reflect the latest page version.SummaryDifference0.1%

- Check113 days agoChange DetectedRevision labels updated from v3.4.1 to v3.4.2, indicating a minor backend/content refresh. No study information or user-facing data are affected.SummaryDifference0.1%

Stay in the know with updates to RC48-ADC in HER2+ Urothelial Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the RC48-ADC in HER2+ Urothelial Cancer Clinical Trial page.